Enteropathy-Associated T-Cell Lymphoma · line 1 · CHOEP (cyclophosphamide + doxorubicin + vincristine + etoposide + prednisone), 6 cycles
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.
| Line of therapy | 1 |
|---|---|
| Track | standard |
| Linked regimen | REG-CHOEP |
| ID | IND-EATL-1L-CHOEP-AUTOSCT |
|---|---|
| Type | Indication |
| Status | reviewed 2026-04-25 | pending_clinical_signoff |
| Diseases | DIS-EATL |
| Sources | SRC-NCCN-BCELL-2025 |
Notes
STUB. Brentuximab-CHP (BV-CHP) — CD30+ EATL варіант, але CD30 expression у EATL варіабельна. Allo-SCT consideration для refractory.
Used By
Algorithms
ALGO-EATL-1L- ALGO-EATL-1L